The Emerging Pathogens Institute is an interdisciplinary research institution associated with the University of Florida.

During the past decade, Emerging Pathogens Institiute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emerging Pathogens Institiute" #1 collaborator was "American Pulse Association" with 2 trials as a collaborator and "Sun-Maid Growers of California" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Emerging Pathogens Institiute" are "Inflammation" (3 trials). Many other conditions were trialed in "Emerging Pathogens Institiute" in a lesser frequency.

Most popular intervention types in "Emerging Pathogens Institiute" are "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Chickpea Enhanced Diet (Short term)" (1 trials), "Observational Chickpea Diet" (1 trials) and "Raisins" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emerging Pathogens Institiute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Emerging Pathogens Institiute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Emerging Pathogens Institiute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emerging Pathogens Institiute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".